Discover 106 paid clinical trials in Huntington, West Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 106
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Huntington WV, Pontiac MI, Atlanta GA, Niagara Falls NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352467
Recruiting
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
for
Diabetic Foot Ulcers
Location: Huntington WV, Pontiac MI, Atlanta GA, Niagara Falls NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352480
Recruiting
Effectiveness of Aurix Therapy in Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Huntington WV, Circleville OH, Pontiac MI, Atlanta GA,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352454
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Huntington WV, Columbus OH, Centerville OH, Franklin OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial